Anticoagulant therapy in oncologic patients undergoing venous stenting for superior vena cava syndrome and other interventional procedures
- PMID: 24464255
- DOI: 10.1007/s00270-013-0791-z
Anticoagulant therapy in oncologic patients undergoing venous stenting for superior vena cava syndrome and other interventional procedures
Comment in
-
Reply to letter re: anticoagulant therapy in oncologic patients undergoing venous stenting for superior vena cava syndrome and other interventional procedures.Cardiovasc Intervent Radiol. 2014 Oct;37(5):1405-6. doi: 10.1007/s00270-013-0792-y. Epub 2013 Nov 23. Cardiovasc Intervent Radiol. 2014. PMID: 24271840 No abstract available.
-
Anticoagulation is not mandatory after stenting for malignant superior vena cava syndrome.Cardiovasc Intervent Radiol. 2014 Oct;37(5):1403-4. doi: 10.1007/s00270-014-0902-5. Epub 2014 May 8. Cardiovasc Intervent Radiol. 2014. PMID: 24806954 No abstract available.
Comment on
-
Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.Cardiovasc Intervent Radiol. 2013 Feb;36(1):140-9. doi: 10.1007/s00270-011-0310-z. Epub 2011 Dec 7. Cardiovasc Intervent Radiol. 2013. PMID: 22146975
-
Life-threatening cerebral edema caused by acute occlusion of a superior vena cava stent.Cardiovasc Intervent Radiol. 2013 Feb;36(1):272-5. doi: 10.1007/s00270-012-0421-1. Epub 2012 May 17. Cardiovasc Intervent Radiol. 2013. PMID: 22588276
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
